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Abstract 22 
 23 
Background: Transsphenoidal surgery is the gold standard for pituitary adenoma 24 
resection. However, despite advances in microsurgical and endoscopic techniques, some 25 
pituitary adenomas can be challenging to cure.  26 
 27 
Objective: To determine whether, in patients undergoing transsphenoidal surgery for 28 
pituitary adenoma, intraoperative ultrasound is a safe and effective technological adjunct. 29 
 30 
Methods: The PubMed database was searched between January 1996 and January 2016 to 31 
identify relevant publications that (1) featured patients undergoing transsphenoidal 32 
surgery for pituitary adenoma, (2) used intraoperative ultrasound, and (3) reported on 33 
safety or effectiveness. Reference lists were also checked and expert opinion sought to 34 
identify further publications. 35 
 36 
Results: Ultimately, ten studies were included comprising one cohort study, seven case 37 
series’ and two case reports. One study reported their prototype probe malfunctioned 38 
leading to false-positive results in two cases, and another study that their prototype probe 39 
was too large to safely enter the sphenoid sinus in two cases. Otherwise, no safety issues 40 
directly related to use of intraoperative ultrasound were reported. In the only comparative 41 
study, remission occurred in 89.7% (61/68) of patients with Cushing’s disease in whom 42 
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intraoperative ultrasound was used, compared with 83.8% (57/68) in whom it was not. 43 
All studies reported that surgeons anecdotally found intraoperative ultrasound helpful.  44 
 45 
Conclusions: Although there is limited and low quality evidence available, the use of 46 
intraoperative ultrasound appears to be a safe and effective technological adjunct to 47 
transsphenoidal surgery for pituitary adenoma. Advances in ultrasound technology may 48 
allow for more widespread use of such devices. 49 
 50 
Keywords: Endoscopy; Neurosurgery; Minimally Invasive Surgery; Ultrasound51 
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INTRAOPERATIVE ULTRASOUND IN PATIENTS UNDERGOING TRANSSPHOIDAL 52 
SURGERY FOR PITUITARY ADENOMA: A SYSTEMATIC REVIEW 53 
Introduction 54 
Transsphenoidal surgery is the gold standard for pituitary adenoma resection. Advances 55 
in microscopy and, more recently, endoscopy represent among the most important 56 
technological innovations in neurosurgery.1 However, some pituitary adenomas remain 57 
challenging to cure. In contemporary series’ approximately a third of patients undergoing 58 
transsphenoidal surgery for pituitary adenoma will have an incomplete resection.2  59 
Several adjuncts have been used to improve resection in patients undergoing 60 
transsphenoidal surgery for pituitary adenoma. Intraoperative CT and MRI offer high-61 
contrast and high-resolution imaging that are familiar to all neurosurgeons, but have 62 
important limitations; the former results in exposure to ionising radiation, the latter 63 
requires specialised non-ferromagnetic instruments, and both are costly and significantly 64 
interrupt the surgical workflow and prolong the operating time.3 To this end, 65 
intraoperative ultrasound has become an increasingly popular tool in neurosurgery, and 66 
provides a relatively inexpensive and simple method of real-time feedback.  67 
The technical specifications for ultrasound probes in transsphenoidal surgery are highly 68 
demanding and conflicting; they must be both slender enough to allow for their use 69 
within a narrow surgical corridor, and provide imaging of sufficient resolution to allow 70 
for meaningful analysis. Nonetheless, ultrasound technology has advanced considerably 71 
over the last 20 years, and several devices suitable for transsphenoidal surgery have now 72 
been developed.  73 
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The aim of the present systematic review was to determine whether, in patients 74 
undergoing transsphenoidal surgery for pituitary adenoma, intraoperative ultrasound is a 75 
safe and effective technological adjunct. 76 
Materials and Methods 77 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 78 
Statement was used in the preparation of this manuscript.4 79 
Search Methods 80 
The PubMed database was searched over a 20-year period between January 1996 and 81 
December 2016. The Boolean search term (microadenoma OR macroadenoma OR 82 
adenoma) AND (pituitary OR hypophysectomy OR transsphenoidal) AND (ultrasound 83 
OR ultrasonography OR sonography) was used. References lists of included articles were 84 
also reviewed, and expert opinion sought, to identify further eligible publications. Two 85 
authors (HJM and TV) independently identified articles using the above search criteria.  86 
Inclusion and exclusion criteria  87 
Titles and abstracts were screened to identify publications that (1) featured patients 88 
undergoing transsphenoidal surgery for pituitary adenoma, (2) used intraoperative 89 
ultrasound, and (3) reported on safety or effectiveness. Full articles were obtained and 90 
further assessed for eligibility. Discrepancies were resolved by discussion with the senior 91 
author. 92 
Data extraction  93 
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The following data was extracted from eligible full articles: (1) study design, (2) study 94 
group characteristics including the number of patients and pathology, (3) ultrasound 95 
device details, and (4) safety and effectiveness including radiological and endocrine 96 
outcomes. 97 
Corresponding authors and device manufacturers were contacted to provide supplemental 98 
data when required.  99 
Appraisal of evidence 100 
The Jadad and Methodological Index for Non-Randomised Studies (MINORS) scoring 101 
systems were used to guide evaluation of the quality of randomised and non-randomised 102 
studies respectively5, 6. Studies of greater quality were given greater weighting in the 103 
qualitative analysis.  104 
Results 105 
A total of 997 articles were pooled from the electronic databases, with an additional 106 
article identified following expert opinion (Figure 1). Of these, 981 articles were 107 
excluded on the basis of their title and abstract because they did not present original data, 108 
did not feature patients undergoing transsphenoidal surgery for pituitary adenoma, did not 109 
include intraoperative ultrasound, or did not report on safety or effectiveness. Full text 110 
screening of the remaining seventeen articles led to the exclusion of a further seven 111 
articles. In all, ten studies were identified that satisfied the inclusion criteria comprising 112 
one cohort study, seven case series’, and two case reports; no randomised studies were 113 
found (Table 1).7-16   114 
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The quality of the included studies was variable (Table 2). Watson et al performed the 115 
only prospective comparative study, which was high quality (MINORS 20/24), although 116 
they did include non-contemporaneous controls. The remaining studies were 117 
retrospective case series’ and case reports; many included non-consecutive patients, 118 
inappropriate or biased assessments of endpoints, and inadequate follow up. None of the 119 
studies documented a prospective calculation of study size. 120 
Ultrasound devices 121 
Bao et al and Ota et al reported the use of Doppler ultrasonography but did not provide 122 
any device or manufacturer details.7, 10 The remaining 8 studies reported the use of 10 123 
different ultrasound systems.  124 
Ultrasound systems vary greatly in their form and function. Ultrasound image quality 125 
depends upon the number of ultrasound elements; placing linear array probe elements on 126 
the side of a probe (side-viewing) allows for a more slender design, while placing these 127 
elements on the front of a probe (forward-viewing) allows for more intuitive imaging of 128 
sellar structures. Similarly, because of frequency-dependent attenuation of ultrasound 129 
waves, there is a trade-off between image resolution and depth.  130 
Several studies used probes designed for transbronchial needle aspiration and 131 
transoesophageal echo (off-label use use).9, 15 Watson et al used two prototype ultrasound 132 
probes specifically designed for transsphenoidal surgery with long and rather thin shaft 133 
dimensions (150x11mm) operating at 12Mhz and 15MHz (Linscan Systems, USA). 134 
Solheim et al initially used a prototype side-looking ultrasound probe with a 3x4mm tip 135 
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diameter and 4mm shaft diameter, operating at 10.3MHz (Vermon, France).13 In a 136 
subsequent study an improved prototype bayonet-shaped forward-looking ultrasound 137 
probe operating at 12MHz was used (Vermon, France).8 The improved probe was, 138 
however, more bulky with a transducer footprint of 12x8mm. Knappe et al used the only 139 
commercially available probe designed for pituitary surgery, the UST-534 probe (Hitachi, 140 
Japan), a forward-looking probe, 9mm in diameter, and operating at 12MHz.12  141 
Solheim et al described the integration of their prototype ultrasound probes with a 142 
neuronavigation platform (Sonowand, Norway).8, 13 They reported that this allowed for 143 
improved image interpretation, particularly when viewing the unfamiliar image 144 
projections of the side-viewing probe. 145 
Safety and effectiveness 146 
Watson et al reported probe malfunction during one day of their study, leading to false-147 
positive results in two cases (2.9%).14 Solheim et al found that their bayonet-shaped 148 
forward-looking probe was too large to safely enter the sphenoid sinus in two cases 149 
(8.3%).8  150 
There were no cases of operative mortality reported in the any of the studies. Several 151 
operative complications were reported that were not directly related to use of 152 
intraoperative ultrasound. In one study a patient sustained injury to the internal carotid 153 
artery and subsequently underwent digital subtraction angiography and stent insertion and 154 
made a good recovery.7 Three studies reported panhypopituitism, and two studies 155 
reported permanent diabetes insipidus as complications following transsphenoidal 156 
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surgery. Other complications included CSF leak, meningitis, monocular blindness, and 157 
cranial nerve palsies. 158 
Several studies explicitly reported on the extent of radiological resection or 159 
endocrinological remission. The pooled rate of complete radiological resection in patients 160 
in whom intraoperative ultrasound was used was 67.1% (range 63.5 to 77.8%) and 161 
endocrine remission was 88.4% (range 76.0 to 100%). Watson et al found remission in 162 
89.7% (61/68) of patients with Cushing’s disease in whom intraoperative ultrasound was 163 
used, compared with 83.8% (57/68) in whom it was not.14 Although this was not 164 
statistically significant (p = 0.45), the authors did subsequently perform a subgroup 165 
analysis of patients undergoing primary rather than revision surgery and found 166 
intraoperative ultrasound helpful. Notably, they found that the use of intraoperative 167 
ultrasound allowed for more frequent identification of adenoma tissue (90% versus 75%; 168 
p = 0.02). 169 
Bao et al reported complete resection in 63.5% (33/52) of patients with pituitary adenoma 170 
invading the cavernous sinus (Knosp grade 3 and 4), and remission in 76.0% (19/25) of 171 
patients with functioning adenoma.7 Solheim et al reported complete resection in 77.8% 172 
(7/9) of patients in their initial and 70.8% (17/24) of patients in their subsequent study.8, 173 
13 Knappe et al reported remission in 100% (18/18) of patients with Cushing’s disease.  174 
All of the studies reported that surgeons anecdotally found ultrasound helpful in 175 
identifying intraoperative anatomy including the internal carotid artery and residual 176 
tumour tissue. 177 
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Discussion 178 
Summary of evidence 179 
At present, there is limited and low quality evidence on the safety and effectiveness of 180 
intraoperative ultrasound in patients undergoing transsphenoidal surgery for pituitary 181 
adenoma. Only ten studies met the inclusion criteria, including only one comparative 182 
study, which failed to demonstrate any statistically significant difference in the primary 183 
outcome. However, none of the studies reported any major safety issues directly related 184 
to use of intraoperative ultrasound, and all of the studies reported that surgeons 185 
anecdotally found intraoperative ultrasound helpful. 186 
Comparison with other studies 187 
The pooled rate of complete radiological resection in patients in whom intraoperative 188 
ultrasound was used was 67.1% (range 63.5 to 77.8%) and endocrine remission was 189 
88.4% (range 76.0 to 100%). Although difficult to make direct comparisons between 190 
heterogeneous groups, these findings are broadly comparable to the reported outcomes of 191 
patients undergoing transsphenoidal surgery for pituitary adenoma with intraoperative CT 192 
and MRI. In a recent study, for example, Berkmann et al found an initial complete 193 
radiological resection rate of 43.5% without intraoperative MRI versus 65.9% with 194 
intraoperative MRI.17  195 
Intraoperative CT and MRI have been more widely used as adjuncts to improve the 196 
resection in patients undergoing transsphenoidal surgery for pituitary adenoma. In a 197 
systematic review, Patel et al identified 24 studies (2 CT and 22 MRI), with improved 198 
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resection in 15-83% of patients.18 Recent guidelines by the Congress of Neurological 199 
Surgeons (CNS), however, found insufficient evidence to recommend their use, 200 
suggesting they may help improve immediate overall gross total resection of 201 
nonfunctioning pituitary adenoma but at the cost of removing normal tissue.19 Indeed, the 202 
present review also identified intraoperative ultrasound probe malfunction leading to 203 
false-positive results in two cases. These studies underscore the importance of experience 204 
in the interpretation of intraoperative imaging for surgical decision making, regardless of 205 
the modality used. 206 
Limitations 207 
The present systematic review has a number of limitations. First, the scarcity and small 208 
size of included studies, means it is likely underpowered to observe small effect sizes. 209 
Second, the fact that all but one of the included studies were retrospective case series’ 210 
and case reports makes it impossible to draw any firm conclusions on the safety and 211 
effectiveness compared to standard transsphenoidal surgery or other intraoperative 212 
modalities. Finally, the technical specifications of the intraoperative ultrasound devices 213 
used, and the experience of the operating surgeon, varied widely in the included studies 214 
making generalisations difficult. Advances intraoperative ultrasound and image guidance 215 
technology, including greater image quality, more ergonomic design, and automated 216 
interpretation, may improve their cost-benefit profile.  217 
Conclusions 218 
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At present there is limited and low quality evidence to support the use of intraoperative 219 
ultrasound in patients undergoing transsphenoidal surgery for pituitary adenoma. Given 220 
the rapid advances in imaging technology, further prospective and comparative 221 
preclinical and clinical studies are warranted to determine the extent to which subjective 222 
benefits to surgeons correspond objective improvement in patient outcomes.  223 
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Figures 286 
Figure 1. PRISMA flow diagram of article selection. 287 
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Table 1.  Summary of included studies. pts = patients; US = ultrasound 
 
Study 
 
Study 
design 
Patients Ultrasound devices Safety  Effectiveness 
Watson 
(1998)14 
Cohort 
study 
136 pts with Cushing’s 
disease and negative or 
equivocal pre-operative 
MRI; 68 pts with US 
and 68 pts without 
Two prototype probes 
(Linscan Systems, 
USA), 150mm long x 
11mm diameter 
operating at 12MHz and 
15MHz respectively 
Malfunction in probe in 
2/68 (2.9%) leading to 
false-positive results 
 
No operative 
complications reported 
 
Remission in 61/68 
(89.7%) with US versus 
57/68 (83.8%) without 
US; in patients 
undergoing primary 
procedures remission in 
54/57 (94.7%) with US 
versus 46/53 (86.8%) 
with US 
Bao 
(2016)7 
Case series 52 pts with pituitary 
adenoma invading the 
cavernous sinus (Knosp 
Grade 3 and 4) 
undergoing extended 
transsphenoidal 
approach 
Doppler US (not 
specified) 
Operative complications: 
carotid injury (1.9%), 
CSF leak (1.9%), 
meningitis (1.9%), 
permanent diabetes 
insipidus (1.9%), 
panhypopituitarism 
(3.8%), monocular 
blindness (1.9%), cranial 
nerve palsies (9.6%)  
Complete resection in 
33/52 (63.5%) 
 
Remission in 19/25 
(76.0%) with 
functioning tumours 
Solheim 
(2016)8 
Case series 24 pts; 20 with 
macroadenoma and 4 
with microadenoma 
Prototype bayonet-
shaped forward-viewing 
probe (Vermon, France), 
120 long x ca 10mm 
diameter, operating at 
12MHz 
Probe too large in 2/24 
(8.3%) 
 
Operative complications: 
Permanent diabetes 
insipidus (4.2%), 
panhypopituitarism 
(4.2%) 
Complete resection in 
17/24 (70.8%) 
 
Remission in 9/10 
(90.0%) with 
functioning adenoma 
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Ishikawa 
(2015)9 
Case series 7 pts; 5 with pituitary 
adenoma 
EB-530US probe for 
transbronchial needle 
aspiration (Fujifilm, 
Japan) for sagittal 
images, 6.7mm 
diameter, operating at 
12MHz 
UST-52110S-5 probe 
for TEE (Aloka, Japan) 
for coronal images, 
4.8mm diameter, 
operating at 3-8MHz 
No operative 
complications reported 
 
Furtado 
(2012)11 
Case series 10 pts with pituitary 
adenoma 
Nicolet Companion 
Micro transducer 
(Nicolet Biomedical, 
USA) for Doppler, 3mm 
diameter, operating at 
10Mhz 
No operative 
complications reported 
 
Knappe 
(2011)12 
Case series 18 pts with Cushing’s 
disease 
UST-534 probe 
connected to an SSD-
3500 SX system (Aloka, 
Japan), 9mm diameter, 
operating at 12MHz 
Operative complications: 
panhypopituitarism 
(5.5%) 
Remission in 18/18 
(100%) 
Solheim  
(2010)13 
Case series 9 pts Prototype side-viewing 
probe (Vermon, France), 
4mm diameter, 
operating at 10MHz 
No operative 
complications reported  
Complete resection in 
7/9 (77.8%) 
Arita 
(1998)15 
Case series 23 pts; 18 with 
macroadenoma and 5 
with microadenoma 
EUP-ES533 biplane 
probe for TEE probe 
with EUB555 color 
Doppler system 
No operative 
complications reported  
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(Hitachi, Japan), 800mm 
flexible shaft x 9.8mm 
diameter, operating at 
7.5MHz; the probe has 
two tandem heads 
performing transverse 
and longitudinal 
imaging respectively 
Ota  
(2013)10 
Case 
report 
One pt with pituitary 
adenoma  
Doppler US (not 
specified) 
No operative 
complications reported 
 
Yamasaki  
(1996)16 
Case 
report 
One pt with acromegaly MF20 and TC2-64 
Doppler US probes 
(Eden Medizinsche 
Elektronik, Germany) 
No operative 
complications reported  
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Table 2. Quality of studies using MINORS criteria 
Study 
(year) 
Clear
ly 
state
d aim 
 
Inclusi
on of 
consec
utive 
patient
s 
 
Prospe
ctive 
collecti
on of 
data 
 
Endpo
ints 
appro
priate 
to the 
aim of 
the 
study 
Unbias
ed 
assess
ment 
of the 
study 
endpoi
nt 
Follow
-up 
period 
appro
priate 
to the 
aim of 
the 
study 
Loss 
to 
follow 
up less 
than 
5% 
 
Prospe
ctive 
calcula
tion of 
the 
study 
size 
An 
adequ
ate 
contro
l 
group 
 
Conte
mpora
ry 
groups 
 
Baseli
ne 
equiva
lence 
of 
groups 
 
Adequ
ate 
statisti
cal 
analysi
s 
 
TOTA
L 
Watson 
(1998)14 
2 2 2 2 2 2 2 0 2 1 2 1 20/24 
Bao 
(2016)7 
2 2 0 2 1 2 2 0 NA NA NA NA 11/16 
Solheim 
(2016)8 
2 0 0 2 1 2 2 0 NA NA NA NA 9/16 
Ishikawa 
(2015)9 
2 0 0 1 1 0 0 0 NA NA NA NA 4/16 
Furtado 
(2012)11 
2 0 0 1 1 0 0 0 NA NA NA NA 4/16 
Knappe 
(2011)12 
2 2 0 2 2 2 2 0 NA NA NA NA 12/16 
Solheim  
(2010)13 
2 0 0 2 1 2 2 0 NA NA NA NA 9/16 
Arita 
(1998)15 
2 2 0 1 1 0 0 0 NA NA NA NA 6/16 
Ota  
(2013)10 
2 0 0 1 1 0 0 0 NA NA NA NA 4/16 
Yamasa
ki  
(1997)16 
2 0 0 1 1 0 0 0 NA NA NA NA 4/16 
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Records identified through database 
searching
(n = 997)
Sc
re
en
in
g
In
cl
ud
ed
El
ig
ib
ili
ty
Id
en
tif
ic
at
io
n
Additional records identified 
through other sources
(n = 1)
Records after duplicates removed
(n = 998)
Records screened
(n = 998)
Records excluded
(n = 981)
Full-text articles assessed 
for eligibility
(n = 17)
Full-text articles excluded
Not able to obtain full 
article (n = 1)
No patients with pituitary 
adenoma (n = 1)
No use of intraoperative 
ultrasound (n = 5)
Studies included in 
qualitative synthesis
(n = 10)
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Abbreviations:  6 
CT = Computed Tomography 7 
 8 
MRI  = Magnetic Resonance Imaging 9 
 10 
CSF = Cerebrospinal fluid11 
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